摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2’,6’-二氟-4’-甲氧苯乙酮 | 886498-84-6

中文名称
2’,6’-二氟-4’-甲氧苯乙酮
中文别名
2',6'-二氟-4'-甲氧苯乙酮;2',6'-二氟-4'-甲氧基苯乙酮
英文名称
1-(2,6-difluoro-4-methoxyphenyl)ethanone
英文别名
1-(2,6-difluoro-4-methoxyphenyl)ethan-1-one;2,6-difluoro-4-methoxyacetophenone
2’,6’-二氟-4’-甲氧苯乙酮化学式
CAS
886498-84-6
化学式
C9H8F2O2
mdl
——
分子量
186.158
InChiKey
YZVNPIUPAKOREH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    224.2±35.0 °C(Predicted)
  • 密度:
    1.213±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2’,6’-二氟-4’-甲氧苯乙酮4-二甲氨基吡啶 、 tetra-N-butylammonium tribromide 作用下, 以 乙醇二氯甲烷乙腈 为溶剂, 反应 14.33h, 生成 N-[4-(2,6-difluoro-4-methoxyphenyl)thiazol-2-yl]pyridine-4-carboxamide
    参考文献:
    名称:
    Discovery of 4-Aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 Inhibitors. Part I: Optimization of in Vitro Potencies and Pharmacokinetic Properties
    摘要:
    A series of 4-aryl-N-arylcarbonyl-2-aminothiazoles of scaffold 4 was designed and synthesized as Hec1/Nek2 inhibitors. Structural optimization of 4 led to compound S 32 bearing C-4' 4-methoxyphenoxy and 4-(o-fluoropyridyl)-carbonyl groups that showed low nanomolar in vitro antiproliferative activity (IC50: 16.3-42.7 nM), high intravenous AUC (64.9 mu M.h, 2.0 mg/kg) in SD rats, and significant in vivo antitumor activity (T/C = 32%, 20 mg/kg, IV) in mice bearing human MDA-MB-231 xenografts. Cell responses resulting from Hec1/Nek2 inhibition were observed in cells treated with 32, including a reduced level of Hec1 coimmunoprecipitated with Nek2, degradation of Nek2, mitotic abnormalities, and apoptosis. Compound 32 showed selectivity toward cancer cells over normal phenotype cells and was inactive in a [H-3]astemizole competitive binding assay for hERG liability screening. Therefore, 32 is as a good lead toward the discovery of a preclinical candidate targeting Hec1/Nek2 interaction.
    DOI:
    10.1021/jm401990s
  • 作为产物:
    描述:
    2-氟-4-甲氧基苯乙酮 在 palladium diacetate 、 silver nitrateN-氟代双苯磺酰胺氨基甲酸甲酯 作用下, 以 二氯甲烷 为溶剂, 反应 24.0h, 以93%的产率得到2’,6’-二氟-4’-甲氧苯乙酮
    参考文献:
    名称:
    Pd催化的芳族酮的直接C(sp2)–H氟化:简洁地获得anacetrapib
    摘要:
    Pd催化的芳族酮的直接邻位-C(sp 2)-H氟化反应是第一次开发。该反应具有良好的区域选择性和简单的操作,是获得氟化酮的另一种快捷方式。通过使用后期C–H氟化作为关键步骤,也可以实现anacetrapib的简明合成。
    DOI:
    10.1039/d1cc01047f
点击查看最新优质反应信息

文献信息

  • Modulators Of HEC1 Activity And Methods Therefor
    申请人:Lau Johnson
    公开号:US20110230486A1
    公开(公告)日:2011-09-22
    Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Especially preferred compounds disrupt Nek2/Hec1 binding and are therefore useful as chemotherapeutic agent for neoplastic diseases.
    提供了用于调节Hec1/Nek2相互作用的化合物、组合物和方法。特别偏爱的化合物会破坏Nek2/Hec1的结合,因此可用作肿瘤疾病的化疗药物。
  • [EN] IMPROVED MODULATORS OF HEC1 ACTIVITY AND METHODS THEREFOR<br/>[FR] MODULATEURS AMÉLIORÉS DE L'ACTIVITÉ HEC1 ET PROCÉDÉS ASSOCIÉS
    申请人:TAIVEX THERAPEUTICS CORP
    公开号:WO2013082324A1
    公开(公告)日:2013-06-06
    Compounds, compositions, and methods for modulation of Hec1/Nek2 interaction are provided. Such compounds disrupt Nek2/Hec1 binding and may be useful as chemotherapeutic agents for neoplastic diseases.
    提供了用于调节Hec1/Nek2相互作用的化合物、组合物和方法。这些化合物破坏了Nek2/Hec1的结合,并可能作为抗肿瘤疾病的化疗药物有用。
  • 8-Substituted isoquinoline derivative and the use thereof
    申请人:Kaneko Shunsuke
    公开号:US20100261701A1
    公开(公告)日:2010-10-14
    The present invention relates to a compound represented by the following formula (1): wherein D 1 , A 1 , D 2 , R 1 , D 3 , and R 2 each have the same meaning as defined in the present specification or a salt thereof. The compound represented by the formula (1) or a salt thereof has an IKKβ inhibiting activity and the like and is useful for the prevention and/or treatment of IKKβ-associated diseases or symptoms and the like.
    本发明涉及一种由以下式(1)表示的化合物: 其中D1,A1,D2,R1,D3和R2分别具有与本说明书中定义的相同含义或其盐。由式(1)表示的化合物或其盐具有IKKβ抑制活性等,对于预防和/或治疗IKKβ相关疾病或症状等方面是有用的。
  • Synthesis of Aryl Ketones by Palladium(II)-Catalyzed Decarboxylative Addition of Benzoic Acids to Nitriles
    作者:Jonas Lindh、Per J. R. Sjöberg、Mats Larhed
    DOI:10.1002/anie.201003009
    日期:2010.10.11
    An efficient, sustainable method for the preparation of aryl ketones from ortho‐substituted benzoic acids proceeds through their decarboxylation to generate an aryl–palladium species, followed by addition to a nitrile and hydrolysis of the intermediate ketimine.
    一种由邻位取代的苯甲酸制备芳基酮的有效,可持续的方法,是通过它们的脱羧反应生成芳基-钯物质,然后加成腈并水解中间酮亚胺。
  • A New Approach to the Synthesis of 2-Aminoimidazo[1,2-<i>a</i>]pyridineDerivatives Through Rapid Parallel Synthesis
    作者:Carlos Jaramillo、J. Eugenio de Diego、Chafiq Hamdouchi
    DOI:10.1055/s-2002-33539
    日期:——
    Different substituted 6-(2,6-difluorobenzoyl)-imidazopyridines 3 have been prepared using rapid parallel synthesis. Key cyanamide intermediate 4 was prepared from chloropyridine 1, and alkylated at the endocyclic nitrogen with different bromoacetophenones (prepared also in rapid parallel synthesis fashion). Subsequent cyclization was performed in situ with EtOAc/H2O to give target molecules.
    利用快速平行合成法制备出了不同取代的 6-(2,6-二氟苯甲酰基)咪唑并吡啶 3。关键的氰酰胺中间体 4 由氯吡啶 1 制备,并与不同的溴苯乙酮(也是通过快速平行合成法制备的)在环内氮处发生烷基化反应。随后用 EtOAc/H2O 原位环化,得到目标分子。
查看更多